Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
about
Recognition and Regulation of T Cells by NK CellsThe Multiple Sclerosis (MS) Genetic Risk Factors Indicate both Acquired and Innate Immune Cell Subsets Contribute to MS Pathogenesis and Identify Novel Therapeutic Opportunities.Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.Current multiple sclerosis treatments have improved our understanding of MS autoimmune pathogenesis.Regulatory Functions of Natural Killer Cells in Multiple Sclerosis.Pharmacodynamic effects of daclizumab in the intrathecal compartment.Acetylcholine-producing NK cells attenuate CNS inflammation via modulation of infiltrating monocytes/macrophagesReply to Liu et al.: Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis.Genetic variant rs763361 regulates multiple sclerosis CD226 gene expression.The role of innate lymphoid cells in health and disease.High resolution HLA analysis reveals independent class I haplotypes and amino-acid motifs protective for multiple sclerosis.Dimethyl fumarate treatment alters NK cell function in multiple sclerosis.Emerging Understanding of the Mechanism of Action for Dimethyl Fumarate in the Treatment of Multiple Sclerosis.Analysis of Lymphocyte Extravasation Using an In Vitro Model of the Human Blood-brain Barrier.Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis.Parasitized Natural Killer cells do not facilitate the spread of Toxoplasma gondii to the brain.Natural Killer Cells Regulate Th17 Cells After Autologous Hematopoietic Stem Cell Transplantation for Relapsing Remitting Multiple Sclerosis.Aberrant STAT phosphorylation signaling in peripheral blood mononuclear cells from multiple sclerosis patients.
P2860
Q26742166-71D7EC1D-4406-4618-A223-6188CBF0ED10Q33572483-585D4C8D-BCE1-4C7F-8CED-88F610C2A5B1Q37337775-432AB148-DBB1-42DB-A93D-7D584DB9FBDAQ38911206-7DE1C38F-961E-499A-819D-5FB6EE2234E2Q39032832-53F6D233-6885-4807-B5F9-4364AB141301Q40962441-483982E5-7FAA-46E8-81EB-352290B710C4Q41256672-A43B5095-A5D8-46FE-9CA9-7ECCA3EA8CDEQ41785267-D9E01505-0E52-4EF0-8C5A-C53B4ABA9F40Q42321746-978D77DC-0518-41B5-8377-D619B9EC5D3AQ48146269-2B79CA59-FBD9-4CDE-89DE-F3F77665255BQ48298402-35724890-3AF8-493E-87DE-13886AE8AD94Q48357779-4A589AF6-17D7-49E9-9469-5549824A9314Q49800939-D643F858-C9E2-436C-9DB8-DB7B77D4FE7AQ50177856-D9C002BD-BDDD-4A60-8A20-6F90642E4281Q52605836-24558AD6-8714-4B03-9ED8-7A3F37707184Q54267050-78B95A83-BE94-48C0-878F-54A08EB6E98FQ54960016-A2B2594A-654E-4DFB-9714-782C0628AB16Q55020152-CCD818C0-DAB1-4DBC-868D-1341864B1C2F
P2860
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impaired NK-mediated regulatio ...... ed by IL-2 receptor modulation
@en
type
label
Impaired NK-mediated regulatio ...... ed by IL-2 receptor modulation
@en
prefLabel
Impaired NK-mediated regulatio ...... ed by IL-2 receptor modulation
@en
P2093
P2860
P50
P356
P1476
Impaired NK-mediated regulatio ...... ed by IL-2 receptor modulation
@en
P2093
Anita Posevitz-Fejfár
Anna Rünzi
Kathrin Held
Klaus Dornmair
Luisa Klotz
Marvin Hartwig
Matea Konjević
Reinhard Hohlfeld
Sven G Meuth
Tanja Kuhlmann
P2860
P304
P356
10.1073/PNAS.1524924113
P407
P50
P577
2016-05-09T00:00:00Z